Ignite Creation Date:
2025-12-24 @ 11:32 PM
Ignite Modification Date:
2025-12-25 @ 9:20 PM
Study NCT ID:
NCT00934856
Status:
COMPLETED
Last Update Posted:
2017-04-06
First Post:
2009-07-06
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of Trastuzumab Emtansine (T-DM1) in Combination With Docetaxel, and Potentially Pertuzumab, in Participants With Advanced Breast Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-07
Start Date Type:
ACTUAL
Primary Completion Date:
2013-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-10
Completion Date Type:
ACTUAL
First Submit Date:
2009-07-06
First Submit QC Date:
None
Study First Post Date:
2009-07-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-02-20
Results First Submit QC Date:
None
Results First Post Date:
2017-04-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-20
Last Update Post Date:
2017-04-06
Last Update Post Date Type:
ACTUAL